Kolexia
Sauvageon-Martre Helene
Pharmacien
Hôpital Saint-Louis
Paris, France
45 Activités
5 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Effets secondaires indésirables des médicaments Infections à VIH Aspergillose Mucormycose Maladies du système nerveux central Lymphomes Lymphome à cellules du manteau Crystalluria

Industries

Novartis
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia -ITD patients.
Haematologica   01 septembre 2023
PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study.
Medical mycology   06 avril 2023
Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients.
Infectious diseases now   27 septembre 2022
Medication adherence in renal transplantation: Evaluation, predictive factors and impact on humoral alloreactivity.
Annales pharmaceutiques francaises   02 juillet 2022
Gilteritinib CSF distribution in a relapsing meningeal acute myeloid leukaemia FLT3-ITD+ patient
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
PKPD relationship assessment of post-MA Dabrafenib plus Trametinib combo in patients with metastatic BRAFV600mut melanoma
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic-pharmacodynamic real-life study.
Cancer chemotherapy and pharmacology   31 mai 2021
Profil des patients traités par Isavuconazole dans un hôpital à orientation onco-hématologique
20es Journées Nationales d’Infectiologie - 5-7 juin 2019 - Centre des Congrès de Lyon   01 juin 2019
Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Therapeutic drug monitoring   09 janvier 2019